Asian equity benchmarks are trading mixed on Monday, as the optimism on covid vaccine rollout been offset with the rise in US-China tensions and as Brexit trade talks in stalemate. Hiking Covid cases worldwide also raised caution in investor sentiments. The global Covid-19 count surpassed 67 million, denting hopes of a faster economic recovery from the pandemic Japan’s Nikkei is trading lower as the exporting got weighed down with the stronger yen. Among the Asian markets, Japan, Singapore, Hong Kong, and China are in lower note. Bucking the trend, South Korea, Taiwan, Indonesia and Malaysia are in positive territory.
Nikkei 225 down by 135.04 points or 0.50% to 26,616.20, Straits Times dipped by 1.50 points or 0.05% to 2,838.39, Hang Seng slipped by 373.48 points or 1.39% to 26,462.44, and Shanghai Composite narrowed by 15.86 points or 0.46% to 3,428.72.
On the flip side, KOSPI Index higher 4.75 points or 0.17% to 2,736.20, Taiwan Weighted increased 84.53 points or 0.60% to 14,216.97, Jakarta Composite rose by 96.94 points or 1.67% to 5,907.42, and FTSE Bursa Malaysia KLCI widened by 0.66 points or 0.04% or 1,622.51.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: